|
시장보고서
상품코드
2073674
용기 밀봉 무결성 시험 시장 : 소재별, 기술별, 포장 형태별, 서비스 유형별, 최종사용자별, 용도별, 국가별, 지역별 - 세계 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)Container Closure Integrity Testing Market, By Material, By Technology, By Packaging Type, By Service Type, By End-user, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
컨테이너·마개 완전성 시험(CCIT) 시장 규모는 2025년에 2억 8,010만 달러로 평가되었고, 2026-2033년 CAGR 10.2%로 성장할 전망입니다.
컨테이너·클로저 무결성 시험(CCIT) 시장은 의약품 및 바이오의약품 포장의 무결성을 검증하는 데 사용되는 장비, 시험 기술 및 검증 서비스로 구성되어 있으며, 무균 제품이 유통기한 동안 누출이나 오염 없이 유지되도록 보장합니다. 이 시장의 성장은 규제 요건의 강화, 주사제 및 바이오의약품 생산 증가, 그리고 제품 품질과 환자 안전에 대한 관심 고조 등에 힘입어 이루어지고 있습니다. 결정론적이고 비파괴적인 시험 기법, 자동화, 그리고 첨단 검사 시스템의 도입 확대가 수요를 더욱 가속화하고 있습니다. 그러나 높은 설비 비용과 복잡한 검증 요건으로 인해 여전히 시장 내 더 광범위한 보급이 제한되고 있습니다.
용기 및 밀봉부 완전성 시험 시장 - 시장 역학
무균 주사제 및 바이오의약품 생산 증가
CCIT 시장의 성장을 뒷받침하는 주요 요인 중 하나는 무균 주사제, 바이오의약품, 백신 및 첨단 치료제의 생산 증가입니다. 무균 주사제 및 생물학적 제제의 추가 개발에 따라, 제약 기업들은 제품의 무균성을 유지하고 미생물 및 습기의 혼입을 방지하기 위해, 제품 수명 주기의 각 단계에 걸쳐 제품의 용기 및 밀봉부의 무결성을 확보하는 데 점점 더 주의를 기울이고 세심하게 노력하고 있습니다. 미국 식품의약국(FDA) 및 미국 약전(USP<1207>) 등의 기관은 무균 제품의 용기 및 밀봉부 완전성 시험에 관한 규제 요건을 정하고 있습니다. 그 결과, CCIT(용기·밀폐성 시험)의 결정론적 기법에 대한 시장이 급속히 확대되고 있습니다. 현재 전 세계 기업들은 80개 이상의 CCIT 브랜드와 40유형 이상의 CCIT 전용 서비스를 제조 및 제공합니다. 생물학적 제제, 프리필드 주사기, 주사제 요법의 지속적인 성장에 더해, 규제 강화로 인해 첨단 용기 및 밀폐성 시험 솔루션에 대한 수요는 앞으로도 계속 증가할 것으로 보입니다.
용기 및 밀봉부 무결성 시험 시장 - 시장 세분화 분석 :
세계 시장 세분화는 소재, 기술, 포장 형태, 서비스 형태, 최종 사용자, 용도 및 지역을 기준으로 이루어집니다.
바이알은 무균 주사제, 백신, 바이오의약품, 동결건조 제품 등 엄격한 품질 보증이 요구되는 의약품 제제에 가장 널리 사용되고 있습니다. 제약사는 약액 포장에 유리제 및 폴리머제 바이알을 사용하고 있습니다. 이는 높은 포장 무결성을 갖추고 있어, 보관 및 유통 과정 모두에서 무균성 요건을 완벽하게 검증할 수 있기 때문입니다. FDA, EMA 및 USP 섹션 1207에서 규정하는 규제 요건이 강화됨에 따라, 바이알 포장 시스템에 대한 견고한 무결성 시험에 대한 수요가 증가하고 있습니다. 주사제, 바이오시밀러, 항암제의 생산이 지속적으로 증가하고 있어, 바이알을 이용한 포장에 대한 견조한 수요가 발생하고 있습니다. 진공 감쇠법이나 고전압 누설 검출법(HVLD)과 같은 결정론적 시험 기술이 널리 채택되고 있는 만큼, 이 제품 유형은 시장에서 계속해서 지배적인 위치를 유지할 것으로 예측됩니다.
의약품 및 바이오의약품 제조 아웃소싱의 확대에 힘입어, 수탁 개발·제조 기관(CDMO) 부문은 용기·밀폐체 무결성 시험(CCIT) 시장에서 가장 큰 기회를 제시하고 있습니다. CDMO가 멸균 주사제, 바이오의약품, 세포 치료제, 유전자 치료제의 생산을 확대함에 따라, 바이알, 주사기, 카트리지 및 기타 약물 전달 시스템의 포장 무결성을 확보해야 할 필요성은 계속해서 높아지고 있습니다. 규제 당국의 감시 강화와 품질 보증 요건의 엄격화로 인해, CDMO 시설 전반에 걸쳐 첨단 CCIT 기술의 도입이 더욱 가속화되고 있습니다.
용기 및 밀봉부 완전성 시험 시장 - 지역별 분석
북미의 컨테이너 클로저 무결성 시험(CCIT) 시장은 선진적인 의약품 제조 인프라, 고도의 바이오의약품 생산, 확립된 의약품 제조 시설의 광범위한 네트워크, 그리고 무균 의약품 포장에 관한 엄격한 규제 요건 등 기존의 강점을 특징으로 하고 있습니다. 미국은 USP<1207>의 결정론적 시험법 활용 확대를 주도하는 역할을 수행하고 있으며, 주사제 개발에 막대한 투자를 하고 있습니다.
예를 들어, 2025년에는 미국 식품의약국(FDA)이 다양한 기업으로부터 50건의 신제품에 대해 승인을 내렸는데, 이러한 신약 중 상당수는 무균성이 검증된 포장이 필요하며, 제품 개발 및 시판 과정에서 CCIT를 받아야 합니다. 미국 FDA는 CCIT 제조 공정의 모든 단계에서 북미에 의약품을 공급하는 등록된 의약품 제조 시설의 광범위한 네트워크를 유지하고 있습니다. 이로 인해 북미 시장, 특히 제약, 생명공학 및 수탁 제조업체에서 CCIT 제품에 대한 지속적인 수요가 발생하고 있습니다.
미국의 용기 밀봉 무결성 시험(CCIT) 시장 - 국가별 분석
미국은 의약품 연구 개발 및 생물학적 제제 제조에 대한 막대한 투자와 FDA의 무균 제품 규제로 인해 USCCIT 시장에서 가장 큰 단일 시장이 되었습니다. 주사용 투여 시스템, 생물학적 제제 및 첨단 기술과 관련된 개발 파이프라인에 포함된 의약품의 수가 증가함에 따라, 신뢰성이 높은 포장 무결성 시험에 대한 수요는 계속해서 높아지고 있습니다. 예를 들어 2025년, FDA는 50건의 신약 승인을 보고했으나, 그중 절반 이상(52%)은 극소수의 환자를 대상으로 한 것이었습니다. 따라서 많은 신형 주사제의 경우, 엄격한 용기 및 밀폐성 검증을 거친 검증된 무균 포장 시스템이 필수적입니다. 미국 제조업체들의 의약품 제조 및 바이오의약품 생산에 대한 투자가 앞으로도 지속될 것으로 예상에 따라, 첨단 패키징 기술을 기반으로 한 결정론적 CCIT 제품 시장은 계속해서 확대될 것입니다.
목차
제1장 용기 밀봉 무결성 시험 시장 개요
제2장 주요 요약
제3장 용기 밀봉 무결성 시험 주요 시장 동향
제4장 용기 밀봉 무결성 시험 산업 분석
제5장 용기 밀봉 무결성 시험 시장 : 높아지는 지정학적 긴장의 영향
제6장 용기 밀봉 무결성 시험 시장 구도
제7장 용기 밀봉 무결성 시험 시장 : 소재별
제8장 용기 밀봉 무결성 시험 시장 : 기술별
제9장 용기 밀봉 무결성 시험 시장 : 포장 유형별
제10장 용기 밀봉 무결성 시험 시장 : 서비스 유형별
제11장 용기 밀봉 무결성 시험 시장 : 최종사용자별
제12장 용기 밀봉 무결성 시험 시장 : 용도별
제13장 용기 밀봉 무결성 시험 시장 : 지역별
제14장 주요 벤더 분석 : 용기 밀봉 무결성 시험 산업
제15장 360도 애널리스트 뷰
LSHContainer Closure Integrity Testing Market size was valued at US$ 280.1 Million in 2025, expanding to a CAGR of 10.2% from 2026 to 2033.
The Container Closure Integrity Testing (CCIT) market comprises instruments, testing technologies, and validation services used to verify the integrity of pharmaceutical and biopharmaceutical packaging, ensuring sterile products remain free from leaks and contamination throughout their shelf life. Market growth is driven by stricter regulatory requirements, increasing production of injectable drugs and biologics, and a stronger focus on product quality and patient safety. Rising adoption of deterministic, non-destructive testing methods, automation, and advanced inspection systems is further accelerating demand. However, high equipment costs and complex validation requirements continue to limit broader market adoption.
Container Closure Integrity Testing Market- Market Dynamics
Rising Production of Sterile Injectable Drugs and Biologics
A large factor behind the growth of the CCIT Market is the rise in producing sterile injectable drugs, biologics, vaccines and advanced therapeutics. With the development of more sterile parenteral products, pharmacies are becoming increasingly mindful and diligent in ensuring container closure integrity for their products throughout each phase of their life cycle, to maintain sterility and prevent contamination with microbes or moisture from entering. Agencies like the U.S. Food and Drug Administration (FDA) and the United States Pharmacopeia (USP <1207>) have regulatory requirements for container closure integrity testing of sterile products. The result is a rapidly growing market for deterministic methods of CCIT. Global companies are currently manufacturing over 80 brands of CCIT technology and over 40 services specific to CCIT. The ongoing growth of biologics, prefilled syringes, drug injection therapies and more stringent regulations will continue to place an increased demand for advanced container closure integrity testing solutions.
Container Closure Integrity Testing Market- Segmentation Analysis:
The worldwide market is segmented based on Material, Technology, Packaging Type, Service Type, End-user, Application, and Region.
Vial's product type was most often used for drug formulations that required strict assurance, including sterile injectable drugs, vaccines and biologics and lyophilized products. Pharmaceutical manufacturers rely on glass and polymer vials for their drug formulation because they have a high degree of packaging integrity that can provide complete validation of the sterility requirement in both the storage and distribution process. Because of the increased regulatory requirements, such as those imposed by the FDA, EMA and USP Section 1207, there is an increased demand for robust integrity testing of vial packaging systems. The continuing increase in production of injectable therapy, biosimilar and oncology drugs is creating a robust demand for vial-based packaging. The same product type is expected to maintain its dominant position in the market because of widespread use of deterministic testing technologies such as vacuum decay and high-voltage leak detection (HVLD).
The Contract Development and Manufacturing Organizations (CDMOs) segment represents the largest opportunity for the container closure integrity testing (CCIT) market, driven by the growing outsourcing of pharmaceutical and biopharmaceutical manufacturing. As CDMOs expand production of sterile injectables, biologics, cell therapies, and gene therapies, the need to ensure packaging integrity for vials, syringes, cartridges, and other drug delivery systems continues to rise. Increasing regulatory scrutiny and quality assurance requirements are further accelerating the adoption of advanced CCIT technologies across CDMO facilities.
Container Closure Integrity Testing Market- Geographical Insights
The Container Closure Integrity Testing (CCIT) Market in North America has been characterized by its traditional strength of having an advanced pharmaceutical manufacturing infrastructure, sophisticated biologics production, an extensive network of established drug manufacturing facilities, and rigorous regulatory requirements related to the packaging of sterile drugs. The US has led the way in promoting the increased use of USP <1207> deterministic testing methods and injecting significant amounts into the development of injectable drugs.
For example, in 2025, the US Food and Drug Administration (FDA) issued approvals for 50 new products from a variety of companies, and many of these new drugs require packaging that is validated as sterile and undergo CCIT during product development and commercialization. The US FDA maintains an extensive network of registered drug manufacturing facilities supplying North America with pharmaceutical products at all stages of the CCIT manufacturing process. This has created continuous demand for CCIT products in the North American market, especially in pharmaceuticals, biotechnology, and contract manufacturers.
United States Container Closure Integrity Testing Market- Country Insights
The US represents the single greatest USCCIT market due to its significant investment in pharmaceutical R&D, manufacturing biologics and the FDA's regulation of sterile products. The increasing number of drugs in the pipeline for injectable delivery systems, biologics and advanced technologies continue to increase the need for reliable package integrity testing. In 2025, for example, the FDA reported the approval of 50 new drugs, but over half of them (52%) were for very few patients; so, many of the new injectable drugs must have validated sterile packaging systems that undergo rigorous container closure integrity validation. The anticipated continuation of US manufacturers investing in drug manufacturing and biologics production will continue to boost the market for advanced deterministic CCIT products.
Container Closure Integrity Testing Market- Competitive Landscape:
The Container Closure Integrity Testing (CCIT) market - competitive landscape is very competitive, as companies have made significant investments into technological innovation, meeting regulatory compliance and producing high-quality, highly-precise testing solutions for pharmaceutical and biotechnology industries. Companies compete based on accuracy of the tests they provide to customers, degree of automation of their products, and support capabilities (for both deterministic & non-destructive inspection).
Companies in the CCIT market frequently employ a variety of strategic initiatives to grow their market share and respond to the evolving needs of this industry through R&D investment, product introductions, and partnerships, as well as expansion into new markets globally. Examples of major players in the CCIT market that are utilizing cutting edge technology along with their global expertise include West Pharmaceutical Services, Inc., INFICON Holding AG, SP Scientific, Uson, L.P., and Shimadzu Corporation. These companies are utilizing leading edge technology to enhance their competitiveness and respond to the growing demands for quality assurance in the marketplace.
Recent Developments:
In May 2026, CS Analytical announced that its enhanced package distribution testing services have now completed their buildout and are fully operational. The enhancements are the result of a significant investment in state-of-the-art ASTM D4169-23 and ISTA testing capabilities, which will include a customized multimodal vibration/temperature/altitude simulation platform for validating packaging of pharmaceutical and medical device products.
In January 2026, Sharp Services disclosed that they are investing over €20 million for expanding their packaging capacity for injectables at their locations in both the Netherlands and Belgium. The new investment will include cold-chain storage, syringe assembly, blister packaging, and GMP production to accommodate the growing demand for injectable drug formats.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Albany Molecular Research Inc. (AMRI)
- Analytical Lab Group
- Berkshire Sterile Manufacturing
- Confarma
- Cormica
- Curia
- DDL and Nelson Labs
- Eurofins Scientific
- Gateway Analytical
- Genesis Packaging Technologies
- Labcorp Drug Development
- Lighthouse Instruments
- Mocon, Inc.
- Nelson Labs
- Pfeiffer Vacuum
- PTI (Packaging Technologies & Inspection)
- Qualitest
- SGS SA
- Stevanato Group
- Toxikon Corporation
- West Pharmaceutical Services
- WIL Research Laboratories
- Wilco
- Others
GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY MATERIAL- MARKET ANALYSIS, 2020 - 2033
- Glass
- Plastic/Polymer
- Elastomer/Rubber Closures
- Others
GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Vacuum Decay (Non-destructive)
- Helium Leak Detection
- High Voltage Leak Detection (HVLD)
- Laser-Based Headspace Analysis
- Dye Ingress
- Microbial Ingress
- Ultrasound Detection
- Others
GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY PACKAGING TYPE- MARKET ANALYSIS, 2020 - 2033
- Vials
- Pre-filled Syringes
- Ampoules
- Cartridges
- IV Bags and Pouches
- Blister Packs
- Bottles
- Others
GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2020 - 2033
- Method Development & Validation
- Routine Integrity Testing
- Stability Testing Support
- Regulatory Compliance Consulting
- Failure Investigations
GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Sterile Product Testing
- Lyophilized Product Testing
- Liquid Drug Product Testing
- Combination Product Testing
GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Development & Manufacturing Organizations (CDMOs)
- Medical Device Companies
- Academic & Research Institutes
GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. Container Closure Integrity Testing Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.2. Competitive Insights
3. Container Closure Integrity Testing Key Market Trends
- 3.1. Container Closure Integrity Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Container Closure Integrity Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Container Closure Integrity Testing Market Opportunities
- 3.4. Container Closure Integrity Testing Market Future Trends
4. Container Closure Integrity Testing Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Container Closure Integrity Testing Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Container Closure Integrity Testing Market Landscape
- 6.1. Container Closure Integrity Testing Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Container Closure Integrity Testing Market - By Material
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Material, 2025 & 2033 (%)
- 7.1.2. Glass
- 7.1.3. Plastic/Polymer
- 7.1.4. Elastomer/Rubber Closures
- 7.1.5. Others
8. Container Closure Integrity Testing Market - By Technology
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
- 8.1.2. Vacuum Decay (Non-destructive)
- 8.1.3. Helium Leak Detection
- 8.1.4. High Voltage Leak Detection (HVLD)
- 8.1.5. Laser-Based Headspace Analysis
- 8.1.6. Dye Ingress
- 8.1.7. Microbial Ingress
- 8.1.8. Ultrasound Detection
- 8.1.9. Others
9. Container Closure Integrity Testing Market - By Packaging Type
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Packaging Type, 2025 & 2033 (%)
- 9.1.2. Vials
- 9.1.3. Pre-filled Syringes
- 9.1.4. Ampoules
- 9.1.5. Cartridges
- 9.1.6. IV Bags and Pouches
- 9.1.7. Blister Packs
- 9.1.8. Bottles
- 9.1.9. Others
10. Container Closure Integrity Testing Market - By Service Type
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Service Type, 2025 & 2033 (%)
- 10.1.2. Method Development & Validation
- 10.1.3. Routine Integrity Testing
- 10.1.4. Stability Testing Support
- 10.1.5. Regulatory Compliance Consulting
- 10.1.6. Failure Investigations
11. Container Closure Integrity Testing Market - By End-user
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By End-user, 2025 & 2033 (%)
- 11.1.2. Pharmaceutical Companies
- 11.1.3. Biotechnology Companies
- 11.1.4. Contract Development & Manufacturing Organizations (CDMOs)
- 11.1.5. Medical Device Companies
- 11.1.6. Academic & Research Institutes
12. Container Closure Integrity Testing Market - By Application
- 12.1. Overview
- 12.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 12.1.2. Sterile Product Testing
- 12.1.3. Lyophilized Product Testing
- 12.1.4. Liquid Drug Product Testing
- 12.1.5. Combination Product Testing
13. Container Closure Integrity Testing Market- By Geography
- 13.1. Introduction
- 13.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 13.2. North America
- 13.2.1. Overview
- 13.2.2. Container Closure Integrity Testing Key Manufacturers in North America
- 13.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 13.2.4. North America Market Size and Forecast, By Material, 2020 - 2033 (US$ Million)
- 13.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 13.2.6. North America Market Size and Forecast, By Packaging Type, 2020 - 2033 (US$ Million)
- 13.2.7. North America Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 13.2.8. North America Market Size and Forecast, By End-user, 2020 - 2033 (US$ Million)
- 13.2.9. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 13.2.10. U.S.
- 13.2.11. Canada
- 13.3. Europe
- 13.3.1. Overview
- 13.3.2. Container Closure Integrity Testing Key Manufacturers in Europe
- 13.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 13.3.4. Europe Market Size and Forecast, By Material, 2020 - 2033 (US$ Million)
- 13.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 13.3.6. Europe Market Size and Forecast, By Packaging Type, 2020 - 2033 (US$ Million)
- 13.3.7. Europe Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 13.3.8. Europe Market Size and Forecast, By End-user, 2020 - 2033 (US$ Million)
- 13.3.9. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 13.3.10. Germany
- 13.3.11. UK
- 13.3.12. France
- 13.3.13. Italy
- 13.3.14. Spain
- 13.3.15. The Netherlands
- 13.3.16. Sweden
- 13.3.17. Russia
- 13.3.18. Poland
- 13.3.19. Denmark
- 13.3.20. Rest of Europe
- 13.4. Asia Pacific (APAC)
- 13.4.1. Overview
- 13.4.2. Container Closure Integrity Testing Key Manufacturers in Asia Pacific
- 13.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 13.4.4. Asia Pacific Market Size and Forecast, By Material, 2020 - 2033 (US$ Million)
- 13.4.5. Asia Pacific Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 13.4.6. Asia Pacific Market Size and Forecast, By Packaging Type, 2020 - 2033 (US$ Million)
- 13.4.7. Asia Pacific Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 13.4.8. Asia Pacific Market Size and Forecast, By End-user, 2020 - 2033 (US$ Million)
- 13.4.9. Asia Pacific Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 13.4.10. China
- 13.4.11. India
- 13.4.12. Japan
- 13.4.13. South Korea
- 13.4.14. Australia
- 13.4.15. Indonesia
- 13.4.16. Thailand
- 13.4.17. Philippines
- 13.4.18. Taiwan
- 13.4.19. Vietnam
- 13.4.20. Rest of APAC
- 13.5. Latin America (LATAM)
- 13.5.1. Overview
- 13.5.2. Container Closure Integrity Testing Key Manufacturers in Latin America
- 13.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 13.5.4. LATAM Market Size and Forecast, By Material, 2020 - 2033 (US$ Million)
- 13.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 13.5.6. LATAM Market Size and Forecast, By Packaging Type, 2020 - 2033 (US$ Million)
- 13.5.7. LATAM Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 13.5.8. LATAM Market Size and Forecast, By End-user, 2020 - 2033 (US$ Million)
- 13.5.9. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 13.5.10. Brazil
- 13.5.11. Mexico
- 13.5.12. Argentina
- 13.5.13. Colombia
- 13.5.14. Rest of LATAM
- 13.6. Middle East and Africa (MEA)
- 13.6.1. Overview
- 13.6.2. Container Closure Integrity Testing Key Manufacturers in Middle East and Africa
- 13.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 13.6.4. MEA Market Size and Forecast, By Material, 2020 - 2033 (US$ Million)
- 13.6.5. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 13.6.6. MEA Market Size and Forecast, By Packaging Type, 2020 - 2033 (US$ Million)
- 13.6.7. MEA Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
- 13.6.8. MEA Market Size and Forecast, By End-user, 2020 - 2033 (US$ Million)
- 13.6.9. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 13.6.10. Saudi Arabia
- 13.6.11. UAE
- 13.6.12. Israel
- 13.6.13. Turkey
- 13.6.14. Algeria
- 13.6.15. Egypt
- 13.6.16. Iran
- 13.6.17. Qatar
- 13.6.18. Rest of MEA
14. Key Vendor Analysis- Container Closure Integrity Testing Industry
- 14.1. Competitive Benchmarking
- 14.1.1. Competitive Dashboard
- 14.1.2. Competitive Positioning
- 14.2. Company Profiles
- 14.2.1. Albany Molecular Research Inc. (AMRI)
- 14.2.2. Analytical Lab Group
- 14.2.3. Berkshire Sterile Manufacturing
- 14.2.4. Confarma
- 14.2.5. Cormica
- 14.2.6. Curia
- 14.2.7. DDL and Nelson Labs
- 14.2.8. Eurofins Scientific
- 14.2.9. Gateway Analytical
- 14.2.10. Genesis Packaging Technologies
- 14.2.11. Labcorp Drug Development
- 14.2.12. Lighthouse Instruments
- 14.2.13. Mocon, Inc.
- 14.2.14. Nelson Labs
- 14.2.15. Pfeiffer Vacuum
- 14.2.16. PTI (Packaging Technologies & Inspection)
- 14.2.17. Qualitest
- 14.2.18. SGS SA
- 14.2.19. Stevanato Group
- 14.2.20. Toxikon Corporation
- 14.2.21. West Pharmaceutical Services
- 14.2.22. WIL Research Laboratories
- 14.2.23. Wilco
- 14.2.24. Others
15. 360 Degree Analyst View
16. Appendix
- 16.1. Research Methodology
- 16.2. References
- 16.3. Abbreviations
- 16.4. Disclaimer
- 16.5. Contact Us
